DK0840621T3 - - Google Patents

Info

Publication number
DK0840621T3
DK0840621T3 DK96928368T DK96928368T DK0840621T3 DK 0840621 T3 DK0840621 T3 DK 0840621T3 DK 96928368 T DK96928368 T DK 96928368T DK 96928368 T DK96928368 T DK 96928368T DK 0840621 T3 DK0840621 T3 DK 0840621T3
Authority
DK
Denmark
Prior art keywords
gestagen
oestrogen
ethoxyethoxy
tts
androgen
Prior art date
Application number
DK96928368T
Other languages
Danish (da)
English (en)
Inventor
Guenter Cordes
Martin Siegmund
Original Assignee
Labtec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labtec Gmbh filed Critical Labtec Gmbh
Application granted granted Critical
Publication of DK0840621T3 publication Critical patent/DK0840621T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Power Steering Mechanism (AREA)
  • Surgical Instruments (AREA)
DK96928368T 1995-07-22 1996-07-22 DK0840621T3 (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19526864A DE19526864A1 (de) 1995-07-22 1995-07-22 Hormonpflaster
PCT/EP1996/003229 WO1997003698A1 (de) 1995-07-22 1996-07-22 Hormonpflaster

Publications (1)

Publication Number Publication Date
DK0840621T3 true DK0840621T3 (is) 2002-04-15

Family

ID=7767564

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96928368T DK0840621T3 (is) 1995-07-22 1996-07-22

Country Status (21)

Country Link
US (1) US5985311A (is)
EP (1) EP0840621B1 (is)
JP (1) JPH11504038A (is)
KR (1) KR19990035795A (is)
CN (1) CN1195994A (is)
AT (1) ATE212234T1 (is)
AU (1) AU6786696A (is)
BR (1) BR9609794A (is)
CA (1) CA2227538A1 (is)
CZ (1) CZ20498A3 (is)
DE (3) DE19526864A1 (is)
DK (1) DK0840621T3 (is)
ES (1) ES2171710T3 (is)
HU (1) HUP9900301A3 (is)
MX (1) MX9800469A (is)
NO (1) NO980277D0 (is)
NZ (1) NZ316026A (is)
PL (1) PL324552A1 (is)
PT (1) PT840621E (is)
SK (1) SK8198A3 (is)
WO (1) WO1997003698A1 (is)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
FR2779062A1 (fr) * 1998-06-02 1999-12-03 Investigations Therapeutiques Preparation sous forme galenique simple visant a limiter les effets induits durant la menopause et posterieurement et traitement avec cette preparation
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
CA2447302C (en) 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
DE60233217D1 (de) 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
KR20030028253A (ko) * 2001-09-27 2003-04-08 (주)지씨아이 잔탄검과 알긴을 이용한 항고지단백혈증 경피투과제제의제조
CA2494915C (en) * 2002-08-09 2012-07-10 Teikoku Seiyaku Co., Ltd. Female hormone-containing patch
JP5027373B2 (ja) * 2002-08-09 2012-09-19 帝國製薬株式会社 エストラジオール含有貼付剤
JP4919573B2 (ja) * 2002-08-09 2012-04-18 帝國製薬株式会社 ノルエチステロン含有外用貼付剤
KR20040037653A (ko) * 2002-10-29 2004-05-07 대한민국(경북대학교 총장) 갈변 방지제
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
CA2554649C (en) 2004-01-30 2015-10-27 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
ES2526700T3 (es) 2004-08-05 2015-01-14 Corium International, Inc. Composición de adhesivo
US20060121102A1 (en) * 2004-09-27 2006-06-08 Chia-Ming Chiang Transdermal systems for the delivery of estrogens and progestins
EP1806151B1 (en) * 2004-11-10 2012-05-23 Hisamitsu Pharmaceutical Co., Inc. Drug for external use and adhesive patch
US20070298089A1 (en) * 2004-11-10 2007-12-27 Masakazu Saeki Drug for External Use and Adhesive Patch
ATE509969T1 (de) * 2005-09-23 2011-06-15 Nat Starch Chem Invest Klebstoffe auf acrylpolymerbasis
US7947304B2 (en) * 2005-11-02 2011-05-24 Transpharma Medical Ltd. Human growth hormone patch formulations
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
CA2696632C (en) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
DE102008059054A1 (de) 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
MX2020012404A (es) 2014-06-06 2022-04-11 Ovid Therapeutics Inc Metodos para incrementar la inhibicion tonica y para tratar insomnio secundario.
CA2951284A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
EP3324961A4 (en) 2015-07-17 2019-03-13 Ovid Therapeutics, Inc. METHOD FOR TREATING DEVELOPMENT DISORDERS WITH GABOXADOL
US9682069B2 (en) 2015-07-17 2017-06-20 Ovid Therapeutics Inc Methods of treating Dravet syndrome
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10660967B2 (en) 2016-10-21 2020-05-26 Augusta University Research Institute, Inc. Curcumin conjugates and methods of use thereof
US10071083B2 (en) 2017-02-03 2018-09-11 Ovid Therapeutics Inc Use of gaboxadol in the treatment of tinnitus
US10953036B2 (en) 2017-11-20 2021-03-23 University Of Georgia Research Foundation, Inc. Compositions and methods of modulating HIF-2A to improve muscle generation and repair
US20210137960A1 (en) 2018-02-01 2021-05-13 Yale University Compositions and methods for inhibition of nuclear-penetrating antibodies
US20240166770A1 (en) 2019-10-18 2024-05-23 Yale University Compositions and methods for inhibition of cell-penetrating antibodies
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US11850220B2 (en) 2020-05-19 2023-12-26 Augusta University Research Institute, Inc. Synthesis of ibuprofen hybrid conjugates as anti-inflammatory and analgesic agents
US11858908B2 (en) 2021-01-19 2024-01-02 Augusta University Research Institute, Inc. Compositions and methods for inhibiting IDO1

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296230A (en) * 1985-02-25 1994-03-22 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
CH674618A5 (is) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
DE68921047T2 (de) * 1988-11-30 1995-06-14 Toyota Motor Co Ltd Apparat zum Antreiben eines piezoelektrischen Elements zum Öffnen oder zum Schliessen eines Ventilteils.
US5154922A (en) * 1988-12-01 1992-10-13 Schering Corporation Compositions for transdermal delivery of estradiol
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
DE3942232A1 (de) * 1989-12-21 1991-06-27 Beiersdorf Ag Schmelzhaftkleber auf acrylatbasis
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
DE4240806A1 (de) * 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JP2847578B2 (ja) * 1992-12-31 1999-01-20 スンキョン インダストリイズ カンパニイ リミテッド 皮膚浸透力を高めた医薬組成物
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
AU7517794A (en) * 1993-08-16 1995-03-14 Cygnus Therapeutic Systems Transdermal delivery system using a combination of permeation enhancers
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
JPH09510697A (ja) * 1994-01-27 1997-10-28 シエーリング アクチエンゲゼルシヤフト １４α，１７α−エタノエストラ−１，３，５（１０）−トリエン−３，１７β−ジオールを含有する経皮投与のための薬剤
WO1996008255A1 (en) * 1994-09-14 1996-03-21 Minnesota Mining And Manufacturing Company Transdermal device for delivery of levonorgestrel
JP4102901B2 (ja) * 1994-09-14 2008-06-18 スリーエム カンパニー 経皮薬剤導入用マトリックス

Also Published As

Publication number Publication date
DE19526864A1 (de) 1997-01-23
DE59608650D1 (de) 2002-03-14
PL324552A1 (en) 1998-06-08
WO1997003698A1 (de) 1997-02-06
KR19990035795A (ko) 1999-05-25
PT840621E (pt) 2002-06-28
NZ316026A (en) 1999-08-30
NO980277L (no) 1998-01-21
HUP9900301A2 (hu) 1999-06-28
AU6786696A (en) 1997-02-18
CN1195994A (zh) 1998-10-14
HUP9900301A3 (en) 1999-11-29
US5985311A (en) 1999-11-16
ATE212234T1 (de) 2002-02-15
CA2227538A1 (en) 1997-02-06
SK8198A3 (en) 1998-06-03
MX9800469A (es) 1998-09-30
DE19680582D2 (de) 1998-10-29
BR9609794A (pt) 1999-03-16
JPH11504038A (ja) 1999-04-06
ES2171710T3 (es) 2002-09-16
NO980277D0 (no) 1998-01-21
CZ20498A3 (cs) 1998-06-17
EP0840621B1 (de) 2002-01-23
EP0840621A1 (de) 1998-05-13

Similar Documents

Publication Publication Date Title
DK0840621T3 (is)
ZA9610729B (en) Transdermal device for the delivery of flurbiprofen.
AU3593597A (en) Medical adhesive bandage, delivery system and method
AU4757496A (en) Biodegradable implant for fracture nonunions
EP0624635A3 (en) Pressure sensitive adhesives for medical use and medical band formed therefrom.
EP0935415A4 (en) METHOD FOR MAKING CONNECTIONS INTO A CELL
AU5740496A (en) Micromechanical device and method for enhancing delivery of compounds through the skin
ES2147858T3 (es) Matriz para el suministro transdermico de farmacos.
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU4743896A (en) Polar, lipophilic pressure-sensitive adhesive compositions and medical devices using same
ZA985863B (en) Transdermal therapeutic system
MX9802360A (es) Adhesivo fundido en caliente sensible a la presion para etiquetas y cintas adhesivas.
NZ308516A (en) Transdermal therapeutic system (tts) for administering testosterone
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
AU7172794A (en) Transdermal delivery system package
ZA200107523B (en) Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.
CA2305432A1 (en) Method for preventing the misuse of a transdermal therapeutic system
AU3723695A (en) Transdermal device for delivery of levonorgestrel
AU5818096A (en) Topical aciclovir preparation
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
IL128768A0 (en) Transdermal therapeutic system containing oestriol
ES2141044A1 (es) Terapia con oxibutinina.
UA23119A (uk) Психотропhий засіб